Synthetic glycans to improve current glycoconjugate vaccines and fight antimicrobial resistance

L Del Bino, KE Østerlid, DY Wu, F Nonne… - Chemical …, 2022 - ACS Publications
Antimicrobial resistance (AMR) is emerging as the next potential pandemic. Different
microorganisms, including the bacteria Acinetobacter baumannii, Clostridioides difficile …

Disease manifestations and pathogenic mechanisms of group A Streptococcus

MJ Walker, TC Barnett, JD McArthur… - Clinical microbiology …, 2014 - Am Soc Microbiol
Streptococcus pyogenes, also known as group A Streptococcus (GAS), causes mild human
infections such as pharyngitis and impetigo and serious infections such as necrotizing …

Discovery of semi-and fully-synthetic carbohydrate vaccines against bacterial infections using a medicinal chemistry approach: focus review

PH Seeberger - Chemical Reviews, 2021 - ACS Publications
The glycocalyx, a thick layer of carbohydrates, surrounds the cell wall of most bacterial and
parasitic pathogens. Recognition of these unique glycans by the human immune system …

Carbohydrate vaccines: develo** sweet solutions to sticky situations?

RD Astronomo, DR Burton - Nature reviews Drug discovery, 2010 - nature.com
Recent technological advances in glycobiology and glycochemistry are paving the way for a
new era in carbohydrate vaccine design. This is enabling greater efficiency in the …

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development

AC Steer, I Law, L Matatolu, BW Beall… - The Lancet infectious …, 2009 - thelancet.com
Summary emm sequence ty** is the most widely used method for defining group A
streptococcal (GAS) strains, and has been applied to isolates in all regions of the world. We …

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

MR Davies, L McIntyre, A Mutreja, JA Lacey, JA Lees… - Nature …, 2019 - nature.com
Abstract Group A Streptococcus (GAS; Streptococcus pyogenes) is a bacterial pathogen for
which a commercial vaccine for humans is not available. Employing the advantages of high …

Correlates of immunity to Group A Streptococcus: a pathway to vaccine development

H Frost, JL Excler, S Sriskandan, A Fulurija - npj Vaccines, 2023 - nature.com
Understanding immunity in humans to Group A Streptococcus (Strep A) is critical for the
development of successful vaccines to prevent the morbidity and mortality attributed to Strep …

Development in the concept of bacterial polysaccharide repeating unit-based antibacterial conjugate vaccines

R Rohokale, Z Guo - ACS infectious diseases, 2023 - ACS Publications
The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx.
The complex glycans in the glycocalyx are involved in various biological events, such as …

Potential targets for next generation antimicrobial glycoconjugate vaccines

F Micoli, P Costantino, R Adamo - FEMS microbiology reviews, 2018 - academic.oup.com
Cell surface carbohydrates have been proven optimal targets for vaccine development.
Conjugation of polysaccharides to a carrier protein triggers a T-cell-dependent immune …

Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria

MY Mistou, IC Sutcliffe… - FEMS microbiology …, 2016 - academic.oup.com
The composition of the Gram-positive cell wall is typically described as containing
peptidoglycan, proteins and essential secondary cell wall structures called teichoic acids …